U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H24O12
Molecular Weight 516.4509
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of 4,5-DICAFFEOYLQUINIC ACID

SMILES

O[C@@H]1C[C@](O)(C[C@@H](OC(=O)\C=C\C2=CC=C(O)C(O)=C2)[C@@H]1OC(=O)\C=C\C3=CC=C(O)C(O)=C3)C(O)=O

InChI

InChIKey=UFCLZKMFXSILNL-PSEXTPKNSA-N
InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(35,24(33)34)11-19(30)23(20)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,35H,11-12H2,(H,33,34)/b7-3+,8-4+/t19-,20-,23-,25+/m1/s1

HIDE SMILES / InChI

Molecular Formula C25H24O12
Molecular Weight 516.4509
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 2
Optical Activity UNSPECIFIED

4,5-Dicaffeoylquinic acid is an active component naturally occurring in many plants such as Helichrysum populifolium, Ipomoea batatas, Centella asiatica, Aster scaber, Artemisia capillaris and green coffee beans to name a few. It was shown to be a pigmentation inhibitor in melanocytes and the effect was explained by suppression of melanogenesis (possibly via TRP-1 gene). 4,5-Dicaffeoylquinic acid is also an inhibitor of human immunodeficiency virus type 1 integrase and can be a promising agent for the treatment of patients with HIV infection.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P17643
Gene ID: 7306.0
Gene Symbol: TYRP1
Target Organism: Homo sapiens (Human)
0.3 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Differential inhibition of reverse transcriptase and cellular DNA polymerase-alpha activities by lignans isolated from Chinese herbs, Phyllanthus myrtifolius Moon, and tannins from Lonicera japonica Thunb and Castanopsis hystrix.
1995 Aug
Antiviral activities of purified compounds from Youngia japonica (L.) DC (Asteraceae, Compositae).
2006 Jun 30
Anti-hepatitis B virus effect and possible mechanism of action of 3,4-o-dicaffeoylquinic Acid in vitro and in vivo.
2012

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
B16-F10 melanocytes were treated with 25 and 50 uM of 4,5-dicaffeoylquinic acid in order to test the inhibitory effect of the compound on melanogenesis. The same concentrations were applied for 48 h in a cell viability assay.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:54:07 UTC 2023
Edited
by admin
on Sat Dec 16 08:54:07 UTC 2023
Record UNII
45777W94HK
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4,5-DICAFFEOYLQUINIC ACID
Common Name English
4,5-DICQA
Common Name English
CYCLOHEXANECARBOXYLIC ACID, 3,4-BIS(((2E)-3-(3,4-DIHYDROXYPHENYL)-1-OXO-2-PROPEN-1-YL)OXY)-1,5-DIHYDROXY-, (1S,3R,4R,5R)-
Systematic Name English
4,5-DI-O-CAFFEOYLQUINIC ACID
Common Name English
Code System Code Type Description
CAS
14534-61-3
Created by admin on Sat Dec 16 08:54:07 UTC 2023 , Edited by admin on Sat Dec 16 08:54:07 UTC 2023
NON-SPECIFIC STEREOCHEMISTRY
PUBCHEM
5281780
Created by admin on Sat Dec 16 08:54:07 UTC 2023 , Edited by admin on Sat Dec 16 08:54:07 UTC 2023
PRIMARY
FDA UNII
45777W94HK
Created by admin on Sat Dec 16 08:54:07 UTC 2023 , Edited by admin on Sat Dec 16 08:54:07 UTC 2023
PRIMARY
CAS
89886-31-7
Created by admin on Sat Dec 16 08:54:07 UTC 2023 , Edited by admin on Sat Dec 16 08:54:07 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> CONSTITUENT ALWAYS PRESENT
Methanol extracts of stevia dry leaves were directly used for LC-MS analysis. Efficient separation and resolution were achieved with diphenyl packing and acetonitrile/water as solvent in the HPLC method. Negative ion mode was used for all MS measurements.
PARENT -> CONSTITUENT ALWAYS PRESENT